Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Clements

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
The American Journal of Medicine|July 1, 1981
The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS)P J Clements, D E Furst, W Cabeen, et al.
Arthritis and Rheumatism|November 1, 1991
Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosisP J Clements, P A Lachenbruch, D E Furst, et al.
The Journal of Laboratory and Clinical Medicine|April 1, 1978
Effect of corticosteroids on the human immune response: comparison of one and three daily 1 gm intravenous pulses of methylprednisoloneP T Fan, D T Yu, P J Clements, et al.
Internationale Zeitschrift Fur Klinische Pharmakologie, Therapie, Und Toxikologie. International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1971
L-dopa and amantadine hydrochloride in Parkinson's diseaseJ D Parkes, K J Zilkha, R P Knill-Jones, et al.
Annals of the Rheumatic Diseases|August 1, 1979
Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteineD E Furst, P J Clements, R Harris, et al.
Life Sciences|September 15, 1977
Daily variation in circulating lymphocyte counts, T and B proportions and responsiveness to phytohemagglutininP T Fan, D T Yu, P J Clements, et al.
Arthritis and Rheumatism|February 1, 1989
Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel diseaseS C Ng, P J Clements, W E Berquist, et al.
AJR. American Journal of Roentgenology|June 1, 1981
Skeletal findings in progressive systemic sclerosis (scleroderma)L W Bassett, K L Blocka, D E Furst, et al.
The Journal of Rheumatology|July 1, 1990
Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucilP J Clements, J B Peter, M S Agopian, et al.
Arthritis and Rheumatism|January 1, 1994
Abnormalities of renal physiology in systemic sclerosis. A prospective study with 10-year followupP J Clements, P A Lachenbruch, D E Furst, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
The American Journal of Medicine|July 1, 1981
The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS)P J Clements, D E Furst, W Cabeen, et al.
Arthritis and Rheumatism|November 1, 1991
Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosisP J Clements, P A Lachenbruch, D E Furst, et al.
The Journal of Laboratory and Clinical Medicine|April 1, 1978
Effect of corticosteroids on the human immune response: comparison of one and three daily 1 gm intravenous pulses of methylprednisoloneP T Fan, D T Yu, P J Clements, et al.
Internationale Zeitschrift Fur Klinische Pharmakologie, Therapie, Und Toxikologie. International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1971
L-dopa and amantadine hydrochloride in Parkinson's diseaseJ D Parkes, K J Zilkha, R P Knill-Jones, et al.
Annals of the Rheumatic Diseases|August 1, 1979
Measurement of clinical change in progressive systemic sclerosis: a 1 year double-blind placebo-controlled trial of N-acetylcysteineD E Furst, P J Clements, R Harris, et al.
Life Sciences|September 15, 1977
Daily variation in circulating lymphocyte counts, T and B proportions and responsiveness to phytohemagglutininP T Fan, D T Yu, P J Clements, et al.
Arthritis and Rheumatism|February 1, 1989
Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel diseaseS C Ng, P J Clements, W E Berquist, et al.
AJR. American Journal of Roentgenology|June 1, 1981
Skeletal findings in progressive systemic sclerosis (scleroderma)L W Bassett, K L Blocka, D E Furst, et al.
The Journal of Rheumatology|July 1, 1990
Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucilP J Clements, J B Peter, M S Agopian, et al.
Arthritis and Rheumatism|January 1, 1994
Abnormalities of renal physiology in systemic sclerosis. A prospective study with 10-year followupP J Clements, P A Lachenbruch, D E Furst, et al.
Pageof 10